{"id":93070,"date":"2025-04-03T11:28:41","date_gmt":"2025-04-03T10:28:41","guid":{"rendered":"https:\/\/helloproject.es\/vigilancia\/desarrollan-unas-gotas-oculares-como-posible-terapia-para-la-retinosis-pigmentaria\/"},"modified":"2025-04-03T11:28:41","modified_gmt":"2025-04-03T10:28:41","slug":"desarrollan-unas-gotas-oculares-como-posible-terapia-para-la-retinosis-pigmentaria","status":"publish","type":"post","link":"https:\/\/helloproject.es\/vigilancia\/desarrollan-unas-gotas-oculares-como-posible-terapia-para-la-retinosis-pigmentaria\/","title":{"rendered":"Desarrollan unas gotas oculares como posible terapia para la retinosis pigmentaria"},"content":{"rendered":"<p>Un equipo mutidisciplinar del Centro de Investigaci\u00f3n Biom\u00e9dica en Red (CIBER), el Centro de Investigaci\u00f3n Pr\u00edncipe Felipe (CIPF) y la Universidad del Pa\u00eds Vasco (UPV\/EHU) ha propuesto un tratamiento para la retinosis pigmentaria, una enfermedad ocular hereditaria, que ha sido probado con \u00e9xito en modelos precl\u00ednicos. El estudio, liderado por Regina Rodrigo (CIPF) con la colaboraci\u00f3n de Jos\u00e9 Luis Pedraz (UPV\/EHU), ha sido publicado en la revista <a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0753332225001568?via%3Dihub\" target=\"_blank\">Biomedicine &amp; Pharmacotherapy<\/a>.<\/p>\n<p>La retinosis pigmentaria es una enfermedad compleja con una alta variabilidad gen\u00e9tica y cl\u00ednica, lo que dificulta tanto el diagn\u00f3stico como el tratamiento adecuado. Actualmente, solo existe una opci\u00f3n terap\u00e9utica aprobada para uno de los m\u00e1s de 130 genes asociados a esta patolog\u00eda.<\/p>\n<p>A pesar de ser de origen gen\u00e9tico, se ha observado que la inflamaci\u00f3n cr\u00f3nica mediada por la mol\u00e9cula TNF\u03b1 desempe\u00f1a un papel clave en la progresi\u00f3n de la enfermedad. En este estudio, se evaluaron las propiedades de las gotas oculares NLC\u2013ADA, as\u00ed como su seguridad en la retina y la c\u00f3rnea, y su capacidad para reducir la inflamaci\u00f3n y la degeneraci\u00f3n retiniana. Estas gotas oculares utilizan el anticuerpo monoclonal adalimumab (ADA) dirigido contra la citoquina TNF\u03b1.<\/p>\n<p><a><\/a><\/p>\n<h2>Disminuci\u00f3n de la inflamaci\u00f3n<\/h2>\n<p>Los resultados indican que las gotas oculares con NLC\u2013ADA mejoran la funci\u00f3n de la retina, y disminuyen la degeneraci\u00f3n y la inflamaci\u00f3n sin causar efectos t\u00f3xicos. Tal y como ha afirmado la investigadora Regina Rodrigo, esta estrategia ofrece \u201cuna v\u00eda no invasiva de administraci\u00f3n y un nuevo enfoque para la lucha contra la retinosis pigmentaria, al ser independiente de los defectos gen\u00e9ticos y potencialmente \u00fatil para otras enfermedades oculares inflamatorias\u201d.<\/p>\n<p>Estas gotas podr\u00edan ser \u00fatiles para otras enfermedades oculares inflamatorias<\/p>\n<p>Adem\u00e1s, esta tecnolog\u00eda ha sido considerada susceptible de patentabilidad, lo que ha llevado a las tres instituciones participantes a solicitar una patente internacional.<\/p>\n<p>Referencia:<\/p>\n<p>Sheyla Velasco, Regina Rodrigo et al. \u201cNoninvasive ocular delivery of adalimumab-loaded nanostructured lipid carriers for targeted retinitis pigmentosa therapy\u201d. <a href=\"https:\/\/doi.org\/10.1016\/j.biopha.2025.117962\" target=\"_blank\">Biomedicine &amp; Pharmacotherapy<\/a> (2025).<\/p>","protected":false},"excerpt":{"rendered":"<p>Un equipo mutidisciplinar del Centro de Investigaci\u00f3n Biom\u00e9dica en Red (CIBER), el Centro de Investigaci\u00f3n Pr\u00edncipe Felipe (CIPF) y la Universidad del Pa\u00eds Vasco (UPV\/EHU) ha propuesto un tratamiento para la retinosis pigmentaria, una enfermedad ocular hereditaria, que ha sido probado con \u00e9xito en modelos precl\u00ednicos. El estudio, liderado por Regina Rodrigo (CIPF) con la [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[5],"tags":[],"class_list":["post-93070","post","type-post","status-publish","format-standard","hentry","category-noticias"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v20.9 (Yoast SEO v27.6) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Desarrollan unas gotas oculares como posible terapia para la retinosis pigmentaria - bip4ex<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/helloproject.es\/vigilancia\/desarrollan-unas-gotas-oculares-como-posible-terapia-para-la-retinosis-pigmentaria\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Desarrollan unas gotas oculares como posible terapia para la retinosis pigmentaria\" \/>\n<meta property=\"og:description\" content=\"Un equipo mutidisciplinar del Centro de Investigaci\u00f3n Biom\u00e9dica en Red (CIBER), el Centro de Investigaci\u00f3n Pr\u00edncipe Felipe (CIPF) y la Universidad del Pa\u00eds Vasco (UPV\/EHU) ha propuesto un tratamiento para la retinosis pigmentaria, una enfermedad ocular hereditaria, que ha sido probado con \u00e9xito en modelos precl\u00ednicos. El estudio, liderado por Regina Rodrigo (CIPF) con la [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/helloproject.es\/vigilancia\/desarrollan-unas-gotas-oculares-como-posible-terapia-para-la-retinosis-pigmentaria\/\" \/>\n<meta property=\"og:site_name\" content=\"bip4ex\" \/>\n<meta property=\"article:published_time\" content=\"2025-04-03T10:28:41+00:00\" \/>\n<meta name=\"author\" content=\"Luis Miguel Mej\u00edas Ramos\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Luis Miguel Mej\u00edas Ramos\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/desarrollan-unas-gotas-oculares-como-posible-terapia-para-la-retinosis-pigmentaria\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/desarrollan-unas-gotas-oculares-como-posible-terapia-para-la-retinosis-pigmentaria\\\/\"},\"author\":{\"name\":\"Luis Miguel Mej\u00edas Ramos\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#\\\/schema\\\/person\\\/3767b0619d59a11570372c821f8619ca\"},\"headline\":\"Desarrollan unas gotas oculares como posible terapia para la retinosis pigmentaria\",\"datePublished\":\"2025-04-03T10:28:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/desarrollan-unas-gotas-oculares-como-posible-terapia-para-la-retinosis-pigmentaria\\\/\"},\"wordCount\":368,\"publisher\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#organization\"},\"articleSection\":[\"Noticias\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/desarrollan-unas-gotas-oculares-como-posible-terapia-para-la-retinosis-pigmentaria\\\/\",\"url\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/desarrollan-unas-gotas-oculares-como-posible-terapia-para-la-retinosis-pigmentaria\\\/\",\"name\":\"Desarrollan unas gotas oculares como posible terapia para la retinosis pigmentaria - bip4ex\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#website\"},\"datePublished\":\"2025-04-03T10:28:41+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/desarrollan-unas-gotas-oculares-como-posible-terapia-para-la-retinosis-pigmentaria\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/desarrollan-unas-gotas-oculares-como-posible-terapia-para-la-retinosis-pigmentaria\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/desarrollan-unas-gotas-oculares-como-posible-terapia-para-la-retinosis-pigmentaria\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Desarrollan unas gotas oculares como posible terapia para la retinosis pigmentaria\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#website\",\"url\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/\",\"name\":\"bip4ex\",\"description\":\"Vigilancia Tecnol\u00f3gica\",\"publisher\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#organization\",\"name\":\"Helloproject.es\",\"url\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/bip4ex.png\",\"contentUrl\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/bip4ex.png\",\"width\":322,\"height\":365,\"caption\":\"Helloproject.es\"},\"image\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#\\\/schema\\\/person\\\/3767b0619d59a11570372c821f8619ca\",\"name\":\"Luis Miguel Mej\u00edas Ramos\",\"url\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/author\\\/luismi\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Desarrollan unas gotas oculares como posible terapia para la retinosis pigmentaria - bip4ex","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/helloproject.es\/vigilancia\/desarrollan-unas-gotas-oculares-como-posible-terapia-para-la-retinosis-pigmentaria\/","og_locale":"es_ES","og_type":"article","og_title":"Desarrollan unas gotas oculares como posible terapia para la retinosis pigmentaria","og_description":"Un equipo mutidisciplinar del Centro de Investigaci\u00f3n Biom\u00e9dica en Red (CIBER), el Centro de Investigaci\u00f3n Pr\u00edncipe Felipe (CIPF) y la Universidad del Pa\u00eds Vasco (UPV\/EHU) ha propuesto un tratamiento para la retinosis pigmentaria, una enfermedad ocular hereditaria, que ha sido probado con \u00e9xito en modelos precl\u00ednicos. El estudio, liderado por Regina Rodrigo (CIPF) con la [&hellip;]","og_url":"https:\/\/helloproject.es\/vigilancia\/desarrollan-unas-gotas-oculares-como-posible-terapia-para-la-retinosis-pigmentaria\/","og_site_name":"bip4ex","article_published_time":"2025-04-03T10:28:41+00:00","author":"Luis Miguel Mej\u00edas Ramos","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Luis Miguel Mej\u00edas Ramos","Tiempo de lectura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/helloproject.es\/vigilancia\/desarrollan-unas-gotas-oculares-como-posible-terapia-para-la-retinosis-pigmentaria\/#article","isPartOf":{"@id":"https:\/\/helloproject.es\/vigilancia\/desarrollan-unas-gotas-oculares-como-posible-terapia-para-la-retinosis-pigmentaria\/"},"author":{"name":"Luis Miguel Mej\u00edas Ramos","@id":"https:\/\/helloproject.es\/vigilancia\/#\/schema\/person\/3767b0619d59a11570372c821f8619ca"},"headline":"Desarrollan unas gotas oculares como posible terapia para la retinosis pigmentaria","datePublished":"2025-04-03T10:28:41+00:00","mainEntityOfPage":{"@id":"https:\/\/helloproject.es\/vigilancia\/desarrollan-unas-gotas-oculares-como-posible-terapia-para-la-retinosis-pigmentaria\/"},"wordCount":368,"publisher":{"@id":"https:\/\/helloproject.es\/vigilancia\/#organization"},"articleSection":["Noticias"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/helloproject.es\/vigilancia\/desarrollan-unas-gotas-oculares-como-posible-terapia-para-la-retinosis-pigmentaria\/","url":"https:\/\/helloproject.es\/vigilancia\/desarrollan-unas-gotas-oculares-como-posible-terapia-para-la-retinosis-pigmentaria\/","name":"Desarrollan unas gotas oculares como posible terapia para la retinosis pigmentaria - bip4ex","isPartOf":{"@id":"https:\/\/helloproject.es\/vigilancia\/#website"},"datePublished":"2025-04-03T10:28:41+00:00","breadcrumb":{"@id":"https:\/\/helloproject.es\/vigilancia\/desarrollan-unas-gotas-oculares-como-posible-terapia-para-la-retinosis-pigmentaria\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/helloproject.es\/vigilancia\/desarrollan-unas-gotas-oculares-como-posible-terapia-para-la-retinosis-pigmentaria\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/helloproject.es\/vigilancia\/desarrollan-unas-gotas-oculares-como-posible-terapia-para-la-retinosis-pigmentaria\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/helloproject.es\/vigilancia\/"},{"@type":"ListItem","position":2,"name":"Desarrollan unas gotas oculares como posible terapia para la retinosis pigmentaria"}]},{"@type":"WebSite","@id":"https:\/\/helloproject.es\/vigilancia\/#website","url":"https:\/\/helloproject.es\/vigilancia\/","name":"bip4ex","description":"Vigilancia Tecnol\u00f3gica","publisher":{"@id":"https:\/\/helloproject.es\/vigilancia\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/helloproject.es\/vigilancia\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/helloproject.es\/vigilancia\/#organization","name":"Helloproject.es","url":"https:\/\/helloproject.es\/vigilancia\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/helloproject.es\/vigilancia\/#\/schema\/logo\/image\/","url":"https:\/\/helloproject.es\/vigilancia\/wp-content\/uploads\/2023\/07\/bip4ex.png","contentUrl":"https:\/\/helloproject.es\/vigilancia\/wp-content\/uploads\/2023\/07\/bip4ex.png","width":322,"height":365,"caption":"Helloproject.es"},"image":{"@id":"https:\/\/helloproject.es\/vigilancia\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/helloproject.es\/vigilancia\/#\/schema\/person\/3767b0619d59a11570372c821f8619ca","name":"Luis Miguel Mej\u00edas Ramos","url":"https:\/\/helloproject.es\/vigilancia\/author\/luismi\/"}]}},"_links":{"self":[{"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/posts\/93070","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/comments?post=93070"}],"version-history":[{"count":0,"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/posts\/93070\/revisions"}],"wp:attachment":[{"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/media?parent=93070"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/categories?post=93070"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/tags?post=93070"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}